SEC Filing: Form 8-K Current report Post date December 23, 2024 Post categories In Uncategorized Filed: 2024-12-23 00:00:00 Filing Summary: Filing Summary Filing Details: SEC Filing Detail Post navigation ←Previous post:SEC Filing: Form S-8→Next post:VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor
VYNE Therapeutics
VYNE Therapeutics